Hims & Hers Health Watchlist

tz-plus logo Hims & Hers Disappoints in Revenue – Analysts Praise Earnings but Warn About GLP-1 Risks

R. Dietenberger
Reading Time: 3 minutes

After the release of Q2 figures, Hims & Hers' share price fell by about 11-13% in after-hours trading on Monday evening, August 4, even though earnings per share slightly exceeded expectations. Analysts were particularly disappointed with the revenue outlook for Q3, while the adjusted EBITDA was above expectations.  Analyst assessment of revenue development The quarterly revenues of $544.8 million were about 1% below the consensus of around $552 million, which was seen by market observers as a missed opportunity. Despite strong annual growth...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In